WinstonWınston
Back
Encompass Health Corporation logo

Encompass Health Corporation

EHC
70
Medical - Care Facilities · Healthcare
Winston Score
70
Winston is happy
A high-quality business with solid fundamentals.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Strong
Growth
Exceptional
Cash Flow
Strong
Stability
Good
Valuation
Strong
Dividends
Good

Winston Score History

The full picture

Encompass Health runs a network of inpatient rehabilitation hospitals across the United States. These hospitals help patients recover from serious medical events like strokes, hip fractures, brain injuries, and spinal cord damage. It is the largest operator of inpatient rehabilitation facilities in the country, with over 160 hospitals in roughly 40 states.

The company makes money by charging for patient stays, with most payments coming from Medicare, Medicaid, and private insurance. Because building and staffing specialized rehab hospitals requires significant expertise and capital, new competitors have a hard time entering the market quickly. The aging U.S. population is a key growth driver, since older adults are more likely to need rehabilitation services after illness or injury. However, the company depends heavily on Medicare reimbursement rates, so any cuts to government healthcare payments would directly hurt its revenue.

Politician Trades

3 trades / 12mo

1 Congressional buy and 2 sells on EHC in the last 12 months.

Unlock the full Smart Money Map — every trade plotted on the price chart with politicians, amounts and returns since each trade. Founder's Deal is $57/mo locked for life.

Unlock politician trades

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+9.6% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+9.9% YoY

YoY Growth Rate

Slow EPS growth

Insider Activity

1.3%ownership

Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

$108M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Encompass Health Corporation is growing revenue at 10% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
100.0%
Premium pricing power — 100.0% gross margin
Profit after running costs
Operating Margin
18.1%
Healthy — 18.1% operating margin
Return on the money invested
ROCE
21.4%
Exceptional — 21.4% return on capital

ROIC between 15% and 25%. Every dollar invested in the business earns 15 to 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+9.5%
Steady sales growth (+9.5% YoY)
Profit growth
EPS YoY
+19.8%
Earnings growing fast (+19.8% YoY)

Healthy double-digit earnings growth — what compounders look like.

How steady the profit is
EPS Consistency
8/8 quarters
Every recent quarter grew earnings vs last year

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
246%
Turns 246% of profit into real cash
Spare cash per sale
FCF Margin
9.1%
Modest free cash flow (9.1%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
1.01
Elevated debt (1.01)
Covers its interest
Interest Cover
8.89x
Comfortably covers interest (8.9x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
19.4x
no trend
Fair value — P/E 19.4

P/E in the normal range. Price is roughly $15 for every $1 of yearly profit.

Cheaper or dearer next year
P/E vs Forward
+3.4
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (19.4 → 16.1)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
0.66%
no trend
Small dividend — 0.66% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record
Dividend Growth
+11.4%
no trend
Dividend growing fast (11.4% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial